Zoetis inc stock.

Dec 3, 2023 · Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats ... The average twelve-month target price among brokers that have issued a report on the stock in the last year is $216.29. A number of research analysts have issued reports on the stock. Argus raised their price target on shares of Zoetis from $190.00 to $201.00 in a report on Tuesday, September 19th. HSBC began coverage on shares of Zoetis in a ...INSTANT CATTLE MARKET PRICES AND INSIGHTS. Cattle Krush gives you prices on feeder cattle, live cattle and corn so you can get instant breakevens, profit alerts and financial projections. Performance Livestock Analytics provides cattle management software to help producers save time and boost profitability.Zoetis Inc. ZTS delivered second-quarter 2023 adjusted earnings (excluding one-time items) of $1.41 per share, which beat the Zacks Consensus Estimate of $1.32 per share.In the year-ago quarter ...

Read Our Latest Research Report on Zoetis. Zoetis Stock Up 1.6 %. NYSE ZTS traded up $2.91 during midday trading on Monday, hitting $182.04. 584,069 shares of the company traded hands, compared to ...The largest individual shareholder of Apple, Inc. is Arthur D. Levinson, with over 1.1 million shares, as of late November 2014. Levinson is currently the non-executive Chairman of the Board of directors for Apple. He joined the Board in 20...The estimated Net Worth of Catherine A. Knupp is at least $17.1 Millón dollars as of 10 November 2021. Catherine Knupp owns over 10,000 units of Zoetis Inc stock worth over $7,791,843 and over the last 11 years he sold ZTS stock worth over $6,035,956. In addition, he makes $3,311,220 as Executive Vice President y President - …

PARSIPPANY, N.J., March 13, 2023 -- ( BUSINESS WIRE )-- Zoetis Inc. (NYSE:ZTS) has been recognized by Ethisphere, a global leader in defining and advancing the standards of ethical business ...Zoetis Inc. (NYSE: ZTS) today announced the completion of the acquisition of Abaxis, a leader in the development, manufacture and marketing of diagnostic instruments for veterinary point-of-care services for US $83 per share in cash, or approximately $2.0 billion in aggregate.

US98978V1035. Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments.Options Flow - Real Time Feed; Put/Call Ratio - Top Bullish; Put Call Ratio - Top Bearish; SECNov 22, 2023 · Zoetis Inc. (NYSE:ZTS) posted its quarterly earnings data on Tuesday, August, 8th. The company reported $1.41 earnings per share for the quarter, topping analysts' consensus estimates of $1.31 by $0.10. The business earned $2.18 billion during the quarter, compared to the consensus estimate of $2.16 billion. Get real-time Zoetis (ZTS) stock price quotes, analyst insights, forecasts, news, and information you need to help your stock trading and investing.Zoetis Declares Fourth Quarter 2023 Dividend. PARSIPPANY, N.J., October 12, 2023--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.375 per share for the fourth ...

Get real-time Zoetis (ZTS) stock price quotes, analyst insights, forecasts, news, and information you need to help your stock trading and investing.

Find the latest Zoetis Inc. (ZTS) stock quote, history, news and other vital information to help you with your stock trading and investing.

Find the latest Zoetis Inc. (ZTS) stock quote, history, news and other vital information to help you with your stock trading and investing.Zoetis (ZTS.NYSE) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Zoetis | Nyse: ZTS | NyseStock buybacks reduce the number of shares outstanding, so the remaining shareholders receive. ... Zoetis Inc. (ZTS) Shareholder Yield . 2.5%. Forward 5-Year Annual EPS Estimate +15.6%.41.99%. Created with Highstock 2.1.8. Zoetis Inc. Annual stock financials by MarketWatch. View the latest ZTS financial statements, income statements and financial ratios.Sanjay owns over 2,779 units of Zoetis Inc stock worth over $462,426 and over the last 14 years he sold ZTS stock worth over $0. In addition, he makes $330,000 as Independent Director at Zoetis Inc. Wallmine is a radically better financial terminal. Sign up in seconds, it's free!

Zoetis Inc. (NYSE: ZTS) is a company that has got both marketing and innovation right in the last decade, which has led to a 4-fold growth in net income since 2013. The company has continued to ...Nov 13, 2023 · Zoetis Inc. : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Mexican Stock Exchange: ZTS ... morningstar.com - November 21 at 3:47 PM. Zoetis to Participate in the Piper Sandler 35th Annual Healthcare Conference. finance.yahoo.com - November 21 at 10:29 AM. Bessemer Group Inc. Has $82.35 Million Stock Holdings in Zoetis Inc. (NYSE:ZTS) marketbeat.com - November 21 at 9:24 AM. Zoetis Inc. (NYSE:ZTS) EVP Roxanne …Headquartered in Parsippany, New Jersey, Zoetis Inc. (NYSE:ZTS) is an animal health medicines, vaccines, and diagnostic products manufacturer. On February 28, 2023, Zoetis Inc. (NYSE:ZTS) stock ...Stocks ZTS Overview U.S.: NYSE About Zoetis Inc. Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic …ZTS | Complete Zoetis Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.4 may 2023 ... Zoetis Inc. (ZTS) lost ~2% on Thursday after the company posted lower-than-expected revenue for for Q1 2023 and reaffirmed its full-year ...

Zoetis shares fell 11% on the day of Q3 results, as investors reacted to a 3.7% decline in its Adjusted EPS. See why we reiterate our buy rating on ZTS stock.

Get the latest Home Depot Inc (HD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Nov 22, 2023 · Zoetis Inc. (NYSE:ZTS) posted its quarterly earnings data on Tuesday, August, 8th. The company reported $1.41 earnings per share for the quarter, topping analysts' consensus estimates of $1.31 by $0.10. The business earned $2.18 billion during the quarter, compared to the consensus estimate of $2.16 billion. Animal health company Zoetis Inc. ( NYSE: ZTS) traded higher Friday as analysts commented on the FDA approval of German drugmaker Boehringer Ingelheim's parasiticide NexGard Plus for dogs. The ...LOS ANGELES, October 6, 2023 - Basepaws, the leader in feline DNA testing and genetics, enters the canine market with the most extensive DNA test for dogs, accelerating the health genetic testing landscape.Basepaws Breed + Health Dog DNA Test helps pet owners shift from reactive to proactive care, offering easy swabbing and mobile-friendly results for a …As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70+ years of innovating ways to predict, prevent, detect and treat animal illness, Zoetis continues to stand by those raising and caring for animals worldwide — from livestock farmers ...Stock buybacks reduce the number of shares outstanding, so the remaining shareholders receive. ... Zoetis Inc. (ZTS) Shareholder Yield . 2.5%. Forward 5-Year Annual EPS Estimate +15.6%.

As pet owners, we want to keep our furry friends safe and secure. Invisible Fence Inc. has been providing pet owners with innovative solutions to keep their pets out of harm’s way for over 40 years. With their advanced technology, Invisible...

Zoetis Stock Rises After Profit Tops Estimates. By Emily Dattilo. Updated May 04, 2023, 11:17 am EDT / Original May 04, 2023, 7:35 am EDT. Share. Resize. Reprints.

Jul 11, 2023 · Information News Events & Presentations Stock Information Financials Governance Contact Zoetis.com Stock Quote Price 175.79 Volume 14 Change -1.18 % Change -0.67% Today's Open 177.87 Previous Close 176.97 Intraday High 178.06 Intraday Low 175.24 52 Week High 194.99 52 Week Low 140.76 Pricing delayed by 20 minutes. Last Updated 11/29/2023 4:00 PM PARSIPPANY, N.J.--(BUSINESS WIRE)-- Zoetis Inc. (NYSE: ZTS) today reported its financial results for the third quarter of 2021 and increased its guidance for full year 2021. The company reported revenue of $2.0 billion for the third quarter of 2021, an increase of 11% compared with the third quarter of 2020.Headquartered in Parsippany, New Jersey, Zoetis Inc. (NYSE:ZTS) is an animal health medicines, vaccines, and diagnostic products manufacturer. On February 28, 2023, Zoetis Inc. (NYSE:ZTS) stock ...Nov 24, 2023 · Zoetis : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nyse: ZTS | Nyse Dec 1, 2023 · Zoetis Inc. is an animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health technology. As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70+ years of innovating ways to predict, prevent, detect and treat animal illness, Zoetis continues to stand by those raising and caring for animals worldwide — from livestock farmers to …So, based on the above formula, the ROE for Zoetis is: 48% = US$2.2b ÷ US$4.6b (Based on the trailing twelve months to June 2023). The 'return' is the income the business earned over the last year.Nov 21, 2023 · Corporate Overview. As the world’s leading animal health company, Zoetis exists to nurture our world and humankind by advancing care for animals. With 70 years of experience innovating a leading portfolio and pipeline of medicines, vaccines, diagnostics, and technologies, we stand by those caring for animals by providing solutions worldwide.

The low in the last 52 weeks of Zoetis stock was 140.76. According to the current price, Zoetis is 125.08% away from the 52-week low. What was the 52-week high for Zoetis stock?Select year: 11/02/2023 8:30 AM ET. Zoetis Quarterly Corporate Performance - Third Quarter 2023. Webcast. Presentation. 09/12/2023 12:55 PM ET. Morgan Stanley 21st Annual Global Healthcare Conference.The estimated Net Worth of Paul Bisaro is at least $38.1 million dollars as of 14 March 2023. Mr. Bisaro owns over 5,000 units of Zoetis Inc stock worth over $13,738,448 and over the last 10 years he sold ZTS stock worth over $24,032,600. In addition, he makes $355,000 as Independent Director at Zoetis Inc.Instagram:https://instagram. swan etfhow much is the copper worth in a pennyhow to buy carnival cruise line stockbest discount dental plan Analyst Forecast. According to 6 analysts, the average rating for ZTS stock is "Strong Buy." The 12-month stock price forecast is $223.0, which is an increase of 24.27% from the latest price. nyse achrthe carson group Get Zoetis Inc (ZTS.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. ... Zoetis Inc. is an animal health company. The Company ... dog insurance no waiting period Nicholas Ashton ZTS stock SEC Form 4 insiders trading. Nicholas has made over 1 trades of the Zoetis Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Nicholas exercised 492 units of ZTS stock worth $87,965 on 30 October 2023.. The largest trade Nicholas's ever made was exercising 492 units of Zoetis Inc …The largest individual shareholder of Apple, Inc. is Arthur D. Levinson, with over 1.1 million shares, as of late November 2014. Levinson is currently the non-executive Chairman of the Board of directors for Apple. He joined the Board in 20...